In last trading session, Cns Pharmaceuticals Inc (NASDAQ:CNSP) saw 4.83 million shares changing hands with its beta currently measuring 1.03. Company’s recent per share price level of $0.11 trading at $0.0 or -1.79% at ring of the bell on the day assigns it a market valuation of $6.32M. That closing price of CNSP’s stock is at a discount of -64445.45% from its 52-week high price of $71.00 and is indicating a premium of 9.09% from its 52-week low price of $0.10. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 4.23 million shares which gives us an average trading volume of 15.52 million if we extend that period to 3-months.

Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information

Upright in the red during last session for losing -1.79%, in the last five days CNSP remained trading in the green while hitting it’s week-highest on Wednesday, 12/18/24 when the stock touched $0.11 price level, adding 12.0% to its value on the day. Cns Pharmaceuticals Inc’s shares saw a change of -99.83% in year-to-date performance and have moved 3.77% in past 5-day. Cns Pharmaceuticals Inc (NASDAQ:CNSP) showed a performance of -13.25% in past 30-days. Number of shares sold short was 1.14 million shares which calculate 0.04 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 0.5 to the stock, which implies a rise of 78.0% to its current value. Analysts have been projecting 0.5 as a low price target for the stock while placing it at a high target of 0.5. It follows that stock’s current price would drop -354.55% in reaching the projected high whereas dropping to the targeted low would mean a loss of -354.55% for stock’s current value.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 17.98% during past 5 years.

Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s Major holders

Insiders are in possession of 1.04% of company’s total shares while institution are holding 0.79 percent of that, with stock having share float percentage of 0.80%. Investors also watch the number of corporate investors in a company very closely, which is 0.79% institutions for Cns Pharmaceuticals Inc that are currently holding shares of the company.